ARCHIVES

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

This article is from The Cancer Letter archive.

Vol. 21 No. 19 | May 12, 1995

Download PDF Visit The Full Archive

Related Articles

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985